D. Purdie

Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma

Olga Kondrashova, Monique Topp, Ksenija Nesic et al. · Nature Communications · 2018 · 292 citations · Full text

Medicine, Molecular Genetics, Oncology +17

The relative risks of hyperglycaemia, obesity and dyslipidaemia in the relatives of patients with Type II diabetes mellitus (Short Communication)

Joanne T.E. Shaw, D. Purdie, H. A. W. Neil et al. · Diabetologia · 1999 · 57 citations · Full text

Medicine, Endocrinology, Diabetology +7

Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients (pts) with metastatic colorectal cancer (mCRC): Results from the BRiTE observational cohort study

Mark Kozloff, Mary M. Sugrue, D. Purdie et al. · Journal of Clinical Oncology · 2008 · 46 citations

Medicine, Oncology, Pharmacology +14

Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses

Eun Young Kang, Dane Cheasley, Cécile Le Page et al. · Modern Pathology · 2020 · 41 citations · Full text

Medicine, Gynecology, Oncology +17

MyD88 and TLR4 Expression in Epithelial Ovarian Cancer

Matthew S. Block, Robert A. Vierkant, Peter Rambau et al. · Mayo Clinic Proceedings · 2018 · 30 citations · Full text

Medicine, Oncology, Pathology +17